Subclinical cardiotoxicity following adjuvant dose-escalated FEC, high-dose chemotherapy, or CMF in breast cancer

We compared adjuvant chemotherapy-related myocardial damage by antimyosin scintigraphy in patients who received either nine cycles of FEC (fluorouracil, epirubicin and cyclophosphamide) where the doses of epirubicin and cyclophosphamide were escalated according to the leucocyte nadir (group I, n = 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Erselcan, T, Kairemo, K J A, Wiklund, T A, Hernberg, M, Blomqvist, C P, Tenhunen, M, Bergh, J, Joensuu, H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374396/
https://www.ncbi.nlm.nih.gov/pubmed/10732745
http://dx.doi.org/10.1054/bjoc.1999.0998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374396/
https://www.ncbi.nlm.nih.gov/pubmed/10732745
http://dx.doi.org/10.1054/bjoc.1999.0998

Ejemplares similares